After seven years bootstrapping a telemedicine platform that has helped tens of thousands of Canadians manage their hormone health, Science&Humans has turned to venture capital (VC) to accelerate its growth as interest in its services has heated up…
…The all-primary, equity component of Science&Humans’ Series A round was led by Pender Ventures, with participation from fellow Vancouver firm Well Health Technologies, Michele Romanow, and undisclosed US healthcare investors, physicians, and longevity experts. CIBC Innovation Banking provided the venture debt.
Read the full article here: https://betakit.com/sciencehumans-raises-10-million-as-hormone-health-enters-the-mainstream/
